Surgical interventions and local therapy for wegener's granulomatosis

Current Opinion in Rheumatology

Volumn 22, Issue 1, 2010, Pages 29-36

  Hernández Rodríguez, José ^a   Hoffman, Gary S ^b   Koening, Curry L ^c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

Interventional procedures; S granulomatosis; Surgery; Wegener

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ENDOSCOPIC SURGERY; INFLAMMATORY DISEASE; KIDNEY FAILURE; LACRIMAL DUCT OCCLUSION; MIDDLE EAR DISEASE; NOSE DISEASE; ORBIT INFLAMMATION; PARANASAL SINUS DISEASE; PRIORITY JOURNAL; REVIEW; SUBGLOTTIC STENOSIS; WEGENER GRANULOMATOSIS;

BRONCHOSCOPY; CICATRIX; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; RESPIRATORY SYSTEM; RESPIRATORY TRACT DISEASES; WEGENER GRANULOMATOSIS;

EID: 73649116749     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/BOR.0b013e328333e9e9     Document Type: Review

References (73)

1. Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983; 98:76-85.
2. Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116:488-498.
3. Hoffman GS, Drucker Y, Cotch MF, et al. Wegener's granulomatosis: patientreported effects of disease on health, function, and income. Arthritis Rheum 1998; 41:2257-2262.
4. Villa-Forte A, Clark TM, Gomes M, et al. Substitution of methotrexate for cyclophosphamide in Wegener granulomatosis: a 12-year single-practice experience. Medicine (Baltimore) 2007; 86:269-277.
5. Lamprecht P, Gross WL. A brief history of Wegener's granulomatosis: on limited, localized, and generalized forms of the disease: comment on the article by the Wegener's Granulomatosis Etanercept Trial Research Group. Arthritis Rheum 2004; 50:334-335; author reply 335-336.
6. Stone JH. Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial. Arthritis Rheum 2003; 48:2299-2309.
7. Jayne D. Update on the European Vasculitis Study Group trials. Curr Opin Rheumatol 2001; 13:48-55.
8. Reinhold-Keller E, Beuge N, Latza U, et al. An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients. Arthritis Rheum 2000; 43:1021-1032.
9. Gubbels SP, Barkhuizen A, Hwang PH. Head and neck manifestations of Wegener's granulomatosis. Otolaryngol Clin North Am 2003; 36:685-705.
10. Orlandi RR, Hwang PH. Perioperative care for advanced rhinology procedures. Otolaryngol Clin North Am 2006; 39:463-473; viii.
11. Hoffman GS, Gross WL. Wegener's granulomatosis: clinical aspects. In Hoffman GS, Weyand CM, editors. Inflammatory diseases of blood vessels. New York: Marcel Dekker, Inc.; 2002. pp. 381-397.
12. Erickson VR, Hwang PH. Wegener's granulomatosis: current trends in diagnosis and management. Curr Opin Otolaryngol Head Neck Surg 2007; 15:170-176.
13. Stegeman CA, Tervaert JW, de Jong PE, Kallenberg CG. Trimethoprimsulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. N Engl J Med 1996; 335:16-20.
14. Doebbeling BN, Breneman DL, Neu HC, et al. Elimination of Staphylococcus aureus nasal carriage in healthcare workers: analysis of six clinical trials with calcium mupirocin ointment. The Mupirocin Collaborative Study Group. Clin Infect Dis 1993; 17:466-474.
15. Cannady SB, Batra PS, Koening C, et al. Sinonasal Wegener granulomatosis: a single-institution experience with 120 cases. Laryngoscope 2009; 119:757-761.
16. Citardi MJ, Batra PS. Intraoperative surgical navigation for endoscopic sinus surgery: rationale and indications. Curr Opin Otolaryngol Head Neck Surg 2007; 15:23-27.
17. Slack R, Bates G. Functional endoscopic sinus surgery. Am Fam Physician 1998; 58:707-718.
18. Rasmussen N. Management of the ear, nose, and throat manifestations of Wegener granulomatosis: an otorhinolaryngologist's perspective. Curr Opin Rheumatol 2001; 13:3-11.
19. Mullace M, Gorini E, Sbrocca M, et al. Management of nasal septal perforation using silicone nasal septal button. Acta Otorhinolaryngol Ital 2006; 26:216-218.
20. Pirsig W, Pentz S, Lenders H. Repair of saddle nose deformity in Wegener's granulomatosis and ectodermal dysplasia. Rhinology 1993; 31:69-72.
21. Congdon D, Sherris DA, Specks U, McDonald T. Long-term follow-up of repair of external nasal deformities in patients with Wegener's granulomatosis. Laryngoscope 2002; 112:731-737.
22. Duffy FJ Jr, Rossi RM, Pribaz JJ. Reconstruction of Wegener's nasal deformity using bilateral facial artery musculomucosal flaps. Plast Reconstr Surg 1998; 101:1330-1333.
23. Takagi D, Nakamaru Y, Maguchi S, et al. Otologic manifestations of Wegener's granulomatosis. Laryngoscope 2002; 112:1684-1690.
24. Kornblut AD, Wolff SM, deFries HO, Fauci AS. Wegener's granulomatosis. Otolaryngol Clin North Am 1982; 15:673-683.
25. Fenton JE, O'Sullivan TJ. The otological manifestations of Wegener's granulomatosis. J Laryngol Otol 1994; 108:144-146.
26. Abou-Elhmd KA, Hawthorne MR, Flood LM. Cochlear implantation in a case of Wegener's granulomatosis. J Laryngol Otol 1996; 110:958-961.
27. Bullen CL, Liesegang TJ, McDonald TJ, DeRemee RA. Ocular complications of Wegener's granulomatosis. Ophthalmology 1983; 90:279-290.
28. Kwan AS, Rose GE. Lacrimal drainage surgery in Wegener's granulomatosis. Br J Ophthalmol 2000; 84:329-331.
29. Jordan DR, Miller D, Anderson RL. Wound necrosis following dacryocystorhinostomy in patients with Wegener's granulomatosis. Ophthalmic Surg 1987; 18:800-803.
30. Wong RJ, Gliklich RE, Rubin PA, Goodman M. Bilateral nasolacrimal duct obstruction managed with endoscopic techniques. Arch Otolaryngol Head Neck Surg 1998; 124:703-706.
31. Holds JB, Anderson RL, Wolin MJ. Dacryocystectomy for the treatment of dacryocystitis patients with Wegener's granulomatosis. Ophthalmic Surg 1989; 20:443-444.
32. Chandler AC Jr, Wadsworth JA. Conjunctivodacryocystostomy. Am J Ophthalmol 1974; 77:830-836.
33. Talar-Williams C, Sneller MC, Langford CA, et al. Orbital socket contracture: a complication of inflammatory orbital disease in patients with Wegener's granulomatosis. Br J Ophthalmol 2005; 89:493-497.
34. Perry SR, Rootman J, White VA. The clinical and pathologic constellation of Wegener granulomatosis of the orbit. Ophthalmology 1997; 104:683-694.
35. Provenzale JM, Mukherji S, Allen NB, et al. Orbital involvement by Wegener's granulomatosis: imaging findings. AJR Am J Roentgenol 1996; 166:929-934.
36. Fechner FP, Faquin WC, Pilch BZ. Wegener's granulomatosis of the orbit: a clinicopathological study of 15 patients. Laryngoscope 2002; 112:1945-1950.
37. Vischio JA, McCrary CT. Orbital Wegener's granulomatosis: a case report and review of the literature. Clin Rheumatol 2008; 27:1333-1336.
38. Taylor SR, Salama AD, Joshi L, et al. Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosis. Arthritis Rheum 2009; 60:1540-1547.
39. Martinez Del Pero M, Chaudhry A, Jones RB, et al. B-cell depletion with rituximab for refractory head and neck Wegener's granulomatosis: a cohort study. Clin Otolaryngol 2009; 34:328-335.
40. Seo P, Specks U, Keogh KA. Efficacy of rituximab in limited Wegener's granulomatosis with refractory granulomatous manifestations. J Rheumatol 2008; 35:2017-2023.
41. Silva F, Garrity JA, Specks U. Debulking surgery for orbital involvement in patients with Wegener's granulomatosis (WG): report of 11 cases. APMIS 2009; 117:S70.
42. Solans-Laque R, Bosch-Gil J, Canela M, et al. Clinical features and therapeutic management of subglottic stenosis in patients with Wegener's granulomatosis. Lupus 2008; 17:832-836.
43. Langford CA, Sneller MC, Hallahan CW, et al. Clinical features and therapeutic management of subglottic stenosis in patients with Wegener's granulomatosis. Arthritis Rheum 1996; 39:1754-1760.
44. Schokkenbroek AA, Franssen CF, Dikkers FG. Dilatation tracheoscopy for laryngeal and tracheal stenosis in patients with Wegener's granulomatosis. Eur Arch Otorhinolaryngol 2008; 265:549-555.
45. Daum TE, Specks U, Colby TV, et al. Tracheobronchial involvement in Wegener's granulomatosis. Am J Respir Crit Care Med 1995; 151:522-526.
46. Screaton NJ, Sivasothy P, Flower CD, Lockwood CM. Tracheal involvement in Wegener's granulomatosis: evaluation using spiral CT. Clin Radiol 1998; 53:809-815.
47. Summers RM, Aggarwal NR, Sneller MC, et al. CT virtual bronchoscopy of the central airways in patients with Wegener's granulomatosis. Chest 2002; 121:242-250.
48. Nouraei SA, Obholzer R, Ind PW, et al. Results of endoscopic surgery and intralesional steroid therapy for airway compromise due to tracheobronchial Wegener's granulomatosis. Thorax 2008; 63:49-52.
49. Lebovics RS, Hoffman GS, Leavitt RY, et al. The management of subglottic stenosis in patients with Wegener's granulomatosis. Laryngoscope 1992; 102:1341-1345.
50. Eliachar I, Chan J, Akst L. New approaches to the management of subglottic stenosis in Wegener's granulomatosis. Cleve Clin J Med 2002; 69 (Suppl 2): SII149-SII151.
51. Hoffman GS, Thomas-Golbanov CK, Chan J, et al. Treatment of subglottic stenosis, due to Wegener's granulomatosis, with intralesional corticosteroids and dilation. J Rheumatol 2003; 30:1017-1021.
52. Gluth MB, Shinners PA, Kasperbauer JL. Subglottic stenosis associated with Wegener's granulomatosis. Laryngoscope 2003; 113:1304-1307.
53. Smith ME, Elstad M. Mitomycin C and the endoscopic treatment of laryngotracheal stenosis: are two applications better than one? Laryngoscope 2009; 119:272-283.
54. Roediger FC, Orloff LA, Courey MS. Adult subglottic stenosis: management with laser incisions and mitomycin-C. Laryngoscope 2008; 118:1542-1546.
55. Shvero J, Shitrit D, Koren R, et al. Endoscopic laser surgery for subglottic stenosis in Wegener's granulomatosis. Yonsei Med J 2007; 48:748-753.
56. Watters K, Russell J. Subglottic stenosis in Wegener's granulomatosis and the nitinol stent. Laryngoscope 2003; 113:2222-2224.
57. Mair EA. Caution in using subglottic stents for Wegener's granulomatosis. Laryngoscope 2004; 114:2060-2061; author reply 2061.
58. McDonald TJ, Neel HB 3rd, DeRemee RA. Wegener's granulomatosis of the subglottis and the upper portion of the trachea. Ann Otol Rhinol Laryngol 1982; 91:588-592.
59. Polychronopoulos VS, Prakash UB, Golbin JM, et al. Airway involvement in Wegener's granulomatosis. Rheum Dis Clin North Am 2007; 33:755-775; vi.
60. Walton EW. Giant-cell granuloma of the respiratory tract (Wegener's granulomatosis). Br Med J 1958; 2:265-270.
61. Cordier JF, Valeyre D, Guillevin L, et al. PulmonaryWegener's granulomatosis: a clinical and imaging study of 77 cases. Chest 1990; 97:906-912.
62. Lee KS, Kim TS, Fujimoto K, et al. Thoracic manifestation of Wegener's granulomatosis: CT findings in 30 patients. Eur Radiol 2003; 13:43-51.
63. Hirsch MM, Houssiau FA, Collard P, et al. A rare case of bronchial stenosis in Wegener's granulomatosis: dramatic response to intravenous cyclophosphamide and oral cotrimoxazole. J Rheumatol 1992; 19:821-824.
64. Tiernan J, Shah C, McGuigan J, Elborn JS. Successful stenting in endobronchial Wegener's granulomatosis. Ulster Med J 2006; 75:155-157.
65. Soo A, Aziz R, Buckley M, Young V. Bronchoplastic procedure for an unusual condition - Wegener's granulomatosis. Interact Cardiovasc Thorac Surg 2009; 9:530-531.
66. Fauci AS, Wolff SM. Wegener's granulomatosis: studies in eighteen patients and a review of the literature. Medicine (Baltimore) 1973; 52:535-561.
67. Allen A, Pusey C, Gaskin G. Outcome of renal replacement therapy in antineutrophil cytoplasmic antibody-associated systemic vasculitis. J Am Soc Nephrol 1998; 9:1258-1263.
68. Elmedhem A, Adu D, Savage CO. Relapse rate and outcome of ANCAassociated small vessel vasculitis after transplantation. Nephrol Dial Transplant 2003; 18:1001-1004.
69. Westman KW, Bygren PG, Olsson H, et al. Relapse rate, renal survival, and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement. J Am Soc Nephrol 1998; 9:842-852.
70. Gera M, Griffin MD, Specks U, et al. Recurrence of ANCA-associated vasculitis following renal transplantation in the modern era of immunosupression. Kidney Int 2007; 71:1296-1301.
71. Koening CL, Langford CA, Kirchner HL, et al. Renal graft survival and patient mortality in Wegener's granulomatosis (WG): a case/control study. Arthritis Rheum 2007; 56:S301.
72. Schmitt WH, van der Woude FJ. Organ transplantation in the vasculitides. Curr Opin Rheumatol 2003; 15:22-28.
73. Nachman PH, Segelmark M, Westman K, et al. Recurrent ANCA-associated small vessel vasculitis after transplantation: a pooled analysis. Kidney Int 1999; 56:1544-1550.